Current Partnerships

May 15th, 2025

CNL awarded for production of Ac-225 for Actineer

Canadian Nuclear Isotope Council honours CNL, Sylvia Fedoruk Centre and Advanced Cyclotron Systems for first cyclotron irradiation of...

Learn more

January 16th, 2025

Actineer Appoints New President and CEO

Actineer, a joint venture between ITM and Canadian Nuclear Laboratories (CNL) Ltd., today announced the appointment of Joseph...

Learn more

October 17th, 2024

Actineer Advances
Ac-225 Production

Chalk River, Ontario, October 17, 2024 – Actineer, the joint venture between ITM and Canadian Nuclear Laboratories (CNL) Ltd., has...

Learn more

December 7th, 2023

Actinium-225 production

Toronto – December 7 2023 – In support of Canadian Nuclear Isotope Council’s (CNIC) goal of ensuring a reliable supply of medical...

Learn more

October 18th, 2023

ITM and CNL Announce the Launch of Actineer

ITM Isotope Technologies Munich SE (ITM), a leading radio- pharmaceutical biotech company, and Canadian Nuclear Laboratories (CNL)

Learn more